We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bifunctional Gold Nanoparticles Destroy Bacterial Pathogens with Antibiotic and Thermal Killing

By LabMedica International staff writers
Posted on 12 Apr 2016
A team of bioengineers has designed a novel class of targeted bifunctional nanoparticles that attacks pathogenic bacteria with both antibiotic and photo-activated thermal killing strokes.

Investigators at the University of Arkansas (Fayetteville, USA) were searching for alternative methods to treat infections caused by the "ESKAPE" group of pathogens (Enterococcus faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which have developed antibiotic resistance and cause the majority of nosocomial infections.

Image: This schematic illustration shows the working principle of the gold nanocage-based, photo-activated anti-bacterial drug delivery system (Photo courtesy of the University of Arkansas).
Image: This schematic illustration shows the working principle of the gold nanocage-based, photo-activated anti-bacterial drug delivery system (Photo courtesy of the University of Arkansas).

Towards this end they developed a nanoparticle drug delivery system based on polydopamine-coated gold nanocages. These nanoparticles could be coated with an antibiotic and labeled with antibodies to guide them to specific bacterial targets. The gold particles could be induced to release the antibiotic while warming to a lethal temperature upon exposure to low levels of laser light.

The investigators used Staphylococcus aureus as a proof-of-principle ESKAPE pathogen to demonstrate that an appropriate antibiotic (daptomycin) could be incorporated into polydopamine-coated gold nanocages and that daptomycin-loaded gold nanocages could be conjugated to antibodies targeting a species-specific surface protein (staphylococcal protein A; Spa) as a means of achieving selective delivery of the nanoparticles directly to the bacterial cell surface.

They reported in the February 16, 2016, online edition of the journal ACS Infectious Diseases that targeting specificity was confirmed by demonstrating a lack of binding to mammalian cells, reduced photothermal and antibiotic killing of the Spa-negative species Staphylococcus epidermidis, and reduced killing of S. aureus in the presence of unconjugated anti-Spa antibodies. In addition, they demonstrated that laser irradiation at levels within the current safety standard for use in humans could be used to achieve both a lethal photothermal effect and controlled release of the antibiotic. The combination of antibiotic action and lethal heat eradicated all detectable S. aureus cells.

While the system was validated using free-floating bacterial cultures of both methicillin-sensitive and methicillin-resistant S. aureus strains, it was subsequently shown to be effective in the context of an established biofilm, thus indicating that this approach could be used to facilitate the effective treatment of intrinsically resistant biofilm infections.

“We believe that this approach could facilitate the effective treatment of infections caused by antibiotic-resistant bacteria, including those associated with bacterial biofilms, which are involved in a wide variety of bacterial infections,” said senior author Dr. Jingyi Chen, assistant professor of chemistry and biochemistry at the University of Arkansas.

Related Links:

University of Arkansas



New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Unit-Dose Packaging solution
HLX
New
Chlamydia Test Kit
CHLAMYTOP
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries